Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 3,8213,840 of 20,252 grants

Completed OTHER RESEARCH-RELATED
CSHL 2023 Conference on Biology of Cancer: Microenvironment & Metastasis
NATIONAL CANCER INSTITUTE Cold Spring Harbor Laboratory United States 2023 – 2024

Biology of Cancer: Microenvironment & Metastasis Cold Spring Harbor, New York September 19 – 23, 2023 ABSTRACT Cancer is now recognized as an abnormal organ where multiple cell...

$150K
USD
Active TRAINING, INDIVIDUAL
Regulation of hematopoiesis during tumor progression
NATIONAL CANCER INSTITUTE Washington University United States 2023 – 2026

Project Summary/Abstract The immune system plays an important role during tumor progression, having the ability to recognize and kill tumor cells (T cells and NK cells) [1]. Unfort...

$476.9K
USD
Active TRAINING, INDIVIDUAL
Effects of entinostat and neoantigen vaccination on bladder cancer
NATIONAL CANCER INSTITUTE University of North Carolina Chapel Hill United States 2023 – 2026

Project Summary/Abstract Bladder cancer is a prevalent and deadly cancer, with over 80,000 new cases and 17,000 deaths annually in the United States. Advanced bladder cancer has on...

$461.3K
USD
Active NON-SBIR/STTR RPGS
Label-free imaging of CAR T cell metabolism
NATIONAL CANCER INSTITUTE Morgridge Institute for Research, Inc United States 2023 – 2028

PROJECT SUMMARY / ABSTRACT The goal of this proposal is to develop non-invasive single-cell technologies to improve the potency of T cell therapies against cancer. The first 6 chim...

$6.62M
USD
Completed TRAINING, INDIVIDUAL
Mechanism of cell lethality following loss of gene expression.
NATIONAL CANCER INSTITUTE University of Massachusetts Med Sch Worc... United States 2023 – 2025

PROJECT SUMMARY The goal of this project is to determine the mechanism by which cell death results from transcriptional inhibition. The consensus model in the field posits that cel...

$324.8K
USD
Active NON-SBIR/STTR RPGS
Engineering In Vivo Chimeric Antigen Receptor Macrophages (CARMs) using mRNA-exosomes for Cancer Immunotherapy
NATIONAL CANCER INSTITUTE University of Tx Md Anderson Can Ctr United States 2023 – 2027

PROJECT SUMMARY Chimeric antigen receptor (CAR) T cell therapy has revolutionized the treatment of hematologic cancers. However, for solid tumors, CAR T cells face challenges inclu...

$5.68M
USD
Active NON-SBIR/STTR RPGS
Defining the Biological Arc of Grade Group 1 Prostate Cancer
NATIONAL CANCER INSTITUTE University of Michigan At Ann Arbor United States 2023 – 2028

The long-term goal of this project is to further reduce the biological uncertainty associated with surveillance for favorable-risk prostate cancer. Although most men with favorable...

$3.57M
USD
Active NON-SBIR/STTR RPGS
Tumor-intrinsic and paracrine roles of endoglin in pancreatic cancer
NATIONAL CANCER INSTITUTE University of Arizona United States 2023 – 2028

ABSTRACT Pancreatic ductal adenocarcinoma (PDAC) is a lethal malignancy featuring early metastasis, late onset of symptoms, and notorious resistance to existing therapies. A critic...

$3.77M
USD
Completed SBIR-STTR RPGS
Human specific STING agonists for the treatment of cancer
NATIONAL CANCER INSTITUTE Stinginn, Llc United States 2023 – 2025

PROJECT SUMMARY Cellular innate immune sensors, such as STING (STIMULATOR OF INTERFERON GENES), have evolved to detect microbial infection of the cell (1-3). STING controls the pot...

$4M
USD
Completed SBIR-STTR RPGS
Prostate Specific Anti-androgen Therapy for Localized Prostate Cancer
NATIONAL CANCER INSTITUTE Alessa Therapeutics, Inc United States 2023 – 2024

Abstract Prostate cancer is the most common malignancy in men worldwide and its incidence is steadily rising. Treatment options for early-stage prostate cancer include radical pros...

$4.06M
USD
Completed SBIR-STTR RPGS
Development of peptide drug conjugates for cancer therapy
NATIONAL CANCER INSTITUTE Molecular Theranostics, Llc United States 2023 – 2025

Abstract The ultimate goal of this project is to develop and commercialize peptide drug conjugates to treat life- threatening triple negative breast cancer. Triple negative breast...

$2.65M
USD
Completed SBIR-STTR RPGS
Tumor Monorail Device for Serial Glioblastoma Biopsy
NATIONAL CANCER INSTITUTE Exvade Bioscience, Inc United States 2023 – 2024

Project Summary/Abstract Glioblastoma (GBM) is one of the most common and deadliest form of malignant brain tumors, with median patient survival of 12-15 months and five-year survi...

$3.99M
USD
Completed SBIR-STTR RPGS
Targeting Macrophages to Treat Soft Tissue Sarcomas
NATIONAL CANCER INSTITUTE Resolute Science, Inc United States 2023 – 2024

PROJECT SUMMARY Soft tissues sarcomas (STS) is a broad term for multiple subtypes of cancer that start in soft tissues. Most STS are treated in the same way in the clinic regardles...

$3.99M
USD
Completed SBIR-STTR RPGS
An Improved Epigenetic Algorithm for Guiding Low Dose CT Lung Cancer Screening
NATIONAL CANCER INSTITUTE Bd Holding, Inc United States 2023 – 2025

SPECIFIC AIMS Approximately 90% of lung cancer results from smoking. Low Dose Computerized Tomography (LDCT) of smokers can detect lung cancer earlier allowing more effective treat...

$8.86M
USD
Completed NON-SBIR/STTR RPGS
Role of a latent OriLyt RNA in KSHV latency in primary effusion lymphoma
NATIONAL CANCER INSTITUTE University of Arkansas for Med Scis United States 2023 – 2025

Project Summary The Kaposi's sarcoma-associated herpesvirus (KSHV) causes the AIDS-defining B cell malignancy, primary effusion lymphoma (PEL). KSHV is found in all tumor cell...

$2.15M
USD
Active NON-SBIR/STTR RPGS
Secondary Cervical Cancer Prevention of Vulnerable Women with HPV and HIV Co-infection in India
NATIONAL CANCER INSTITUTE University of California-Irvine United States 2023 – 2028

ABSTRACT In India, cervical cancer (CC) remains one of the most common malignancies among women, with about 100,000 women diagnosed annually. HIV promotes the progression of precan...

$6.1M
USD
Completed NON-SBIR/STTR RPGS
Combining immunotherapy with molecularly targeted radiation therapy
NATIONAL CANCER INSTITUTE University of California, San Francisco United States 2023 – 2024

PROJECT SUMMARY/ABSTRACT Immune checkpoint inhibitors (ICI) have limited single agent activity in metastatic castration resistant prostate cancer (mCRPC), in part related to the lo...

$6.63M
USD
Active NON-SBIR/STTR RPGS
Defining the role of tumoral MHC Class I Expression in Mediating Colorectal Cancer Racial Disparities
NATIONAL CANCER INSTITUTE Ohio State University United States 2023 – 2028

PROJECT SUMMARY Compared to Whites, African American/Blacks (AA/B) have a substantially higher (40-50%) colorectal cancer (CRC) mortality rate that is a function of both higher inc...

$6.43M
USD
Active NON-SBIR/STTR RPGS
Ultra-High Performance Brain-dedicated PET scanner for Neurology and Neuro-oncology imaging
NATIONAL CANCER INSTITUTE Weill Medical Coll of Cornell Univ United States 2023 – 2028

1 2 functions, 3 have 4 spatial resolution and sensitivity. Such specifications impact both neurologic and neuro-oncologic diseases. In 5 the former, they allow detecting, quantita...

$5.43M
USD
Completed NON SBIR/STTR CONTRACTS
DATA MANAGEMENT FOR CANCER DIAGNOSIS PROGRAM ACTIVITIES
NATIONAL CANCER INSTITUTE Information Management Services, Inc United States 2023 – 2024

The National Cancer Institute (NCI) is an institute within the National Institutes of Health (NIH), one of eight agencies that compose the Public Health Service (PHS), Department o...

$8.42M
USD